4.5 Article

Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis

期刊

RESPIRATORY RESEARCH
卷 20, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s12931-019-1058-2

关键词

Idiopathic pulmonary fibrosis; Fibroblast-to-myofibroblast transformation; Metabolic shift; Aerobic glycolysis; Lactate dehydrogenase; TGF-1; Human lung fibroblasts

资金

  1. Boehringer Ingelheim Pharma GmbH Co.

向作者/读者索取更多资源

BackgroundIdiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease characterized by aberrant fibroblast activation and progressive fibrotic remodelling of the lungs. Though the exact pathophysiological mechanisms of IPF remain unknown, TGF-1 is thought to act as a main driver of the disease by mediating fibroblast-to-myofibroblast transformation (FMT). Recent reports have indicated that a metabolic shift towards aerobic glycolysis takes place during FMT and that metabolic shifts can directly influence aberrant cell function. This has led to the hypothesis that inhibition of lactate dehydrogenase 5 (LDH5), an enzyme responsible for converting pyruvate into lactate, could constitute a therapeutic concept for IPF.MethodsIn this study, we investigated the potential link between aerobic glycolysis and FMT using a potent LDH5 inhibitor (Compound 408, Genentech). Seahorse analysis was performed to determine the effect of Compound 408 on TGF-1-driven glycolysis in WI-38 fibroblasts. TGF-1-mediated FMT was measured by quantifying -smooth muscle actin (-SMA) and fibronectin in primary human lung fibroblasts following treatment with Compound 408. Lactate and pyruvate levels in the cell culture supernatant were assessed by LC-MS/MS. In addition to pharmacological LDH5 inhibition, the effect of siRNA-mediated knockdown of LDHA and LDHB on FMT was examined.ResultsWe show that treatment of lung fibroblasts with Compound 408 efficiently inhibits LDH5 and attenuates the TGF-1-mediated metabolic shift towards aerobic glycolysis. Additionally, we demonstrate that LDH5 inhibition has no significant effect on TGF-1-mediated FMT in primary human lung fibroblasts by analysing -SMA fibre formation and fibronectin expression.ConclusionsOur data strongly suggest that while LDH5 inhibition can prevent metabolic shifts in fibroblasts, it has no influence on FMT and therefore glycolytic dysregulation is unlikely to be the sole driver of FMT.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据